Skip to main content
. 2021 Mar 1;13(3):392. doi: 10.3390/v13030392

Figure 2.

Figure 2

The replicative advantage of the VOC, 20A.EU1, and the D614G strain. (A) The ratio of the VOC to 20A.EU1 sequences collected in weeks 38–51 of 2020 in England. The trend line is fitted to data points from weeks 43–51 (blue) and from weeks 43–47 (red). The weekly growth rate is 1.88 [95% CI: 1.75–2.01] for weeks 43–51 and 2.24 [95% CI: 2.03–2.48] for weeks 43–47. (B) Stabilization of fits shown in panel A with time-shifting date of the last submission. (C) The ratio of the 20A.EU1 to non-20A.EU1 non-VOC D614G genomes collected in weeks 29–51 of 2020 in England. The trend line is fitted to data points from weeks 34–45. The weekly growth rate is 1.25 [95% CI: 1.23–1.28]. (D) The ratio of the D614G to D614 genomes collected in weeks 11–27 of 2020 in England. The trend line is fitted to data points from weeks 11–24. The weekly growth rate is 1.44 [95% CI: 1.40–1.48]. Data points for selected weeks are labeled with ratios of the counts of genome sequences. Panels A, C and D are based on GISAID data submitted till 12 February 2021 (provided in Supplementary Data File S1).